subsidiary pharmaceutical division dutch chemical group akzo said agreed cooperate drug research and development with organon will receive world clinical development and marketing rights for any products pioneered under agreement with firm organon spokesman said gave further details two companies will looking drugs treat ailments nervous system alzheimer disease which often affects elderly said reuter 